Live-cell imaging of cell-to-cell variability in caspase-8 FRET reporter activity and cell fate trajectory modeling - Dataset (ID:20232)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein | Protein Concentration | Protein Conc Unit | Antibody Name | Antibody Concentration | Antibody Conc Unit | 2nd Antibody Name | 2nd Antibody Concentration | 2nd Antibody Conc Unit | Replicate | Mean log10(k) (a.u.) | Mean tau (min) | Surviving Fraction | Classification Accuracy (theta_T) | Classification Accuracy (fate boundary) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HeLa ICRP | Apomab | 200.0 | nM | 2 | -6.34 | 213.4375 | 0.929 | 0.94643 | 0.78571 | |||||||||
| HeLa ICRP | Mapatumumab | 200.0 | nM | 1 | -4.94 | 155.5995 | 0.386 | 0.81055 | 0.74820 | |||||||||
| HeLa ICRP | Apomab | 200.0 | nM | anti-Fc | 200.0 | nM | 2 | -5.80 | 251.2577 | 0.896 | 0.95706 | 0.87730 | ||||||
| HeLa ICRP | Mapatumumab | 200.0 | nM | anti-Fc | 200.0 | nM | 2 | -4.69 | 101.5925 | 0.438 | 0.79391 | 0.66979 | ||||||
| HeLa ICRP | Apomab | 200.0 | nM | anti-Fc | 200.0 | nM | 1 | -5.73 | 280.2000 | 0.794 | 0.92571 | 0.84000 | ||||||
| HeLa ICRP | Mapatumumab | 200.0 | nM | anti-Fc | 200.0 | nM | 1 | -4.52 | 86.0180 | 0.228 | 0.82635 | 0.80040 | ||||||
| HeLa ICRP | Mapatumumab | 200.0 | nM | 2 | -4.88 | 139.2290 | 0.458 | 0.83900 | 0.70068 | |||||||||
| HeLa ICRP | Apomab | 200.0 | nM | 1 | -6.25 | 250.2333 | 0.940 | 0.96667 | 0.85333 | |||||||||
| HeLa ICRP | Apomab | 100.0 | nM | anti-Fc | 100.0 | nM | 3 | -5.67 | 243.5165 | 0.863 | 0.94505 | 0.84066 | ||||||
| HeLa ICRP | Apomab | 100.0 | nM | anti-Fc | 100.0 | nM | 1 | -5.59 | 246.1950 | 0.843 | 0.91195 | 0.75472 | ||||||
| HeLa ICRP | Apomab | 100.0 | nM | anti-Fc | 100.0 | nM | 2 | -5.57 | 204.0816 | 0.810 | 0.89116 | 0.78231 | ||||||
| HeLa ICRP | Mapatumumab | 100.0 | nM | 2 | -4.60 | 107.2881 | 0.373 | 0.72155 | 0.70460 | |||||||||
| HeLa ICRP | Apomab | 100.0 | nM | 3 | -6.54 | 273.3562 | 0.911 | 0.95205 | 0.84932 | |||||||||
| HeLa ICRP | Mapatumumab | 100.0 | nM | 3 | -4.95 | 157.5059 | 0.388 | 0.85106 | 0.72104 | |||||||||
| HeLa ICRP | Mapatumumab | 100.0 | nM | anti-Fc | 100.0 | nM | 1 | -4.50 | 87.7636 | 0.273 | 0.80364 | 0.73091 | ||||||
| HeLa ICRP | Apomab | 100.0 | nM | 2 | -6.31 | 231.7647 | 0.971 | 0.98529 | 0.85294 | |||||||||
| HeLa ICRP | Mapatumumab | 100.0 | nM | anti-Fc | 100.0 | nM | 2 | -4.57 | 88.4746 | 0.369 | 0.65085 | 0.66780 | ||||||
| HeLa ICRP | Apomab | 100.0 | nM | 1 | -6.13 | 217.8947 | 0.934 | 0.92763 | 0.77632 | |||||||||
| HeLa ICRP | Mapatumumab | 100.0 | nM | anti-Fc | 100.0 | nM | 3 | -4.54 | 86.0039 | 0.218 | 0.84016 | 0.79337 | ||||||
| HeLa ICRP | Mapatumumab | 100.0 | nM | 1 | -5.11 | 190.0427 | 0.604 | 0.84046 | 0.71225 | |||||||||
| HeLa ICRP | Apomab | 50.0 | nM | 1 | -6.39 | 285.0388 | 0.953 | 0.95349 | 0.85271 | |||||||||
| HeLa ICRP | Apomab | 50.0 | nM | anti-Fc | 50.0 | nM | 1 | -5.50 | 240.5143 | 0.794 | 0.93143 | 0.81143 | ||||||
| HeLa ICRP | Apomab | 50.0 | nM | 2 | -6.48 | 250.9659 | 0.972 | 0.98864 | 0.80682 | |||||||||
| HeLa ICRP | Apomab | 50.0 | nM | anti-Fc | 50.0 | nM | 2 | -5.58 | 216.2613 | 0.820 | 0.96396 | 0.81532 | ||||||
| HeLa ICRP | Apomab | 25.0 | nM | 6 | -6.53 | 267.1805 | 0.838 | 0.85338 | 0.84962 |